AzTrials
AzTrials

Smokeless Tobacco CessationNCT06637358

A Text-based Reduction Intervention for Smokeless Tobacco Cessation- Pilot Study

A study testing Extended Scheduled Gradual Reduction (SGR) and Quit Coach in people with Smokeless Tobacco Cessation, run by Duke University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

All participants will receive the EnufSnuff.TXT scheduled gradual reduction (SGR) intervention for 6 weeks and, for those who do not reach the point of quit, includes getting randomized (like the flip of a coin) into either an additional 8-10 weeks of the EnufSnuff.TXT intervention or into receiving an additional 8-10… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Smokeless Tobacco Cessation
What is being tested?
Extended Scheduled Gradual Reduction (SGR) and Quit Coach
Could I receive a placebo?
No, everyone receives an active treatment
How many people
69 participants
Where
1 siteUnited States
Study dates
5 Nov 2024to 4 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 18 years of age and older
  • Have used smokeless tobacco for the last year, currently dip 3 or more times a day
  • Have an address in a rural census tract defined by a RUCC code of 4-10 and/or an IMU of 62 or lower
  • Interested in participating in a cessation program; and
  • Have access to a cell phone with unlimited texting ability.

Who cannot join

  • Non-English speaking;
  • Have smoked cigarettes or used any other tobacco product in the past 30 days (i.e., dual user) and are not willing to abstain during the intervention period
  • Currently participating in a smokeless tobacco cessation study.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University

    Durham, North Carolina, 27708

Other trials in United States

About this study

All participants will receive the EnufSnuff.TXT scheduled gradual reduction (SGR) intervention for 6 weeks and, for those who do not reach the point of quit, includes getting randomized (like the flip of a coin) into either an additional 8-10 weeks of the EnufSnuff.TXT intervention or into receiving an additional 8-10 weeks of the EnufSnuff.TXT intervention along with a dedicated text quit coach to send and receive live support.

Read the detailed description

All participants will receive the EnufSnuff.TXT intervention (a text-based personalized reduction plan and daily text-based cessation support messages) for 6 weeks and, for those who report that they have not achieved complete cessation, includes getting randomized into either an additional 8-10 weeks of the EnufSnuff.TXT intervention or into receiving an additional 8-10 weeks of the EnufSnuff.TXT intervention along with a dedicated quit coach to send and receive live text support. The investigators will conduct phone-based or smart phone-based assessments with participants at baseline, end of program, and 7-month follow-up after intervention completion. The investigators will also conduct a brief midpoint check (after the first 6 weeks of intervention) with participants to ask if they have quit using smokeless tobacco. Research staff will email participants redcap surveys at baseline, end of program, and 7-months. Participants will be able to opt for a recorded telephone interview at the 7-month check-in. Each opted-in participant will be interviewed only once.

Being tested
Extended Scheduled Gradual Reduction (SGR), Quit Coach
Keywords
Smokeless Tobacco, Quitting Smokeless Tobacco, Quit Coach
Medical subject headings
Tobacco Use Cessation, Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Extended Scheduled Gradual Reduction (SGR)Behavioural

    The extended SGR program will allow participants additional time to reduce smokeless tobacco use until they reach zero. The intent of this program is to reduce the number of times participants use smokeless tobacco down to zero. Participants will also receive text-based support messages.

  • Quit CoachBehavioural

    Weekly check-ins and support will be given to this group via the quit coach interactions. The intent of this program is to reduce the number of times participants use smokeless tobacco down to zero. Participants will also receive text-based support messages.

Study groups in NCT06637358
Study groupRoleWhat they receive
Extended Scheduled Gradual Reduction (SGR)Active comparatorExtended scheduled gradual reduction. Participants are asked to gradually reduce smokeless tobacco usage.
Receives: Behavioral: Extended Scheduled Gradual Reduction (SGR)
Quit Coach and Extended Scheduled Gradual Reduction (SGR)ExperimentalExtended scheduled gradual reduction given with the extra support of a live text-based coach. Participants are asked to gradually reduce smokeless tobacco usage and engage in weekly check-ins with their assigned quit coach.
Receives: Behavioral: Extended Scheduled Gradual Reduction (SGR); Behavioral: Quit Coach

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility as measured by the number of recruited individuals who enrolled

    Measured: Baseline

  2. Feasibility as measured by the number of participants who left the study (attrition)

    Measured: Up to 6 months

  3. Acceptability as measured by the number of participants who found the intervention useful

    As measured via telephone interview.

    Measured: Up to 6 months

  4. Acceptability as measured by the number of participants who reported that the intervention received changed their smokeless tobacco use

    As measured via telephone interview.

    Measured: Up to 6 months

  5. Acceptability as measured by the number of participants who reported that the intervention made them think about quitting

    As measured via telephone interview.

    Measured: Up to 6 months

  6. Acceptability as measured by the number of participants who reported that they would recommend the program to a friend

    As measured via telephone interview.

    Measured: Up to 6 months

  7. Preliminary efficacy as measured by the number of participants who quit smokeless tobacco by the end of treatment

    Measured: Up to approximately 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Oct 2024
  2. Study start5 Nov 2024
  3. Primary completion4 Nov 2025
  4. Study completion4 Nov 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
69 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06637358
Sponsor's protocol ID
Pro00103410 _1
Status last verified
Dec 2025
First submitted
9 Oct 2024
Last updated
16 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Extended Scheduled Gradual Reduction (SGR) and Quit Coach in people with Smokeless Tobacco Cessation, run by Duke University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility as measured by the number of recruited individuals who enrolled (time frame: Baseline). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in